Inventor
Daniel Tavares
Inventor
Natick, MA, US
Overview
Patents· 47 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides27%
A61KPreparations for medical, dental or toiletry purposes26%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
C12NMicroorganisms or enzymes6%
C07HSugars5%
PatentTitleYear
11,104,740Antibodies and assays for detection of CD37202110,988,531Conjugates comprising cell-binding agents and cytotoxic agents202110,919,969Anti-CD123 antibodies and conjugates and derivatives thereof202110,875,925Anti-CD123 antibodies and conjugates and derivatives thereof202010,752,683Folate receptor 1 antibodies and immunoconjugates and uses thereof202010,613,093Diagnostic assays and kits for detection of folate receptor 1202010,544,230Methods of using antibodies to detect folate receptor 1 (FOLR1)202010,442,865Methods of use of anti-CD123 antibodies and antigen-binding fragments thereof201910,301,385Folate receptor 1 antibodies and immunoconjugates and uses thereof201910,202,460CD37-binding molecules and immunoconjugates thereof201910,180,432Diagnostic assays and kits for detection of folate receptor 12019RE047123EPHA2 receptor antagonist antibodies201810,077,313Anti-CD123 antibodies and conjugates and derivatives thereof201810,017,578Methods of treating cancer in a patient by administering anti-folate-receptor-1 (FOLR1) antibodies201810,000,566Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same20189,822,183'CA6 antigen-specific cytotoxic conjugate and methods of using the same'20179,702,881'Diagnostic assays and kits for detection of folate receptor 1'20179,676,864'Antibodies that specifically bind to the EphA2 receptor'20179,670,279'Folate receptor 1 antibodies and immunoconjugates and uses thereof'20179,670,280'Folate receptor 1 antibodies and immunoconjugates and uses thereof'20179,670,278'Folate receptor 1 antibodies and immunoconjugates and uses thereof'20179,657,100'Folate receptor 1 antibodies and immunoconjugates and uses thereof'20179,637,547'Monoclonal antibodies for detection of folate receptor 1'20179,598,490'Folate receptor 1 antibodies and immunoconjugates and uses thereof'20179,370,584'CA6 antigen-specific cytotoxic conjugate and methods of using the same'20169,359,442'Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same'20169,346,887'CD37-binding molecules and immunoconjugates thereof'20169,200,073'Diagnostic assays and kits for detection of folate receptor 1'20159,175,086'CD20 antibodies and uses thereof'20159,133,275'Folate receptor 1 antibodies and immunoconjugates and uses thereof'20158,992,912'Methods of use for antibodies that specifically bind to the EphA2 receptor'20158,987,424'CA6 antigen-specific cytotoxic conjugate and methods of using the same'20158,765,917'CD37-binding molecules and immunoconjugates thereof'20148,747,851'Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same'20148,668,910'Antibodies that specifically bind to the EphA2 receptor'20148,557,966'Folate receptor 1 antibodies and immunoconjugates and uses thereof'20138,460,667'EPHA2 receptor antagonist antibodies'20138,337,855'Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same'20128,268,617'Anti-IGF-I receptor antibodies, DNAs, vectors, host cells and genetic constructs'20128,153,765'Anti-CD38 antibodies for the treatment of cancer'20128,119,787'Molecular tools for manufacturing anti-CD33 antibodies and fragments'20128,034,904'Anti-IGF-I receptor antibody'20117,985,842'Anti-IGF-I receptor antibody'20117,834,155'CA6 antigen-specific cytotoxic conjugate and methods of using the same'20107,557,189'Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same'20097,538,195'Anti-IGF-I receptor antibody'20097,342,110'Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2021Patents assigned to IMMUNOGEN INC (39)· patent assignee history
2008–2021Based in Natick, MA, US· patent location history
2012–2014Patents assigned to TAVARES DANIEL (7)· patent assignee history
2012–2016Patents assigned to TAVARES DANIEL J (4)· patent assignee history
2012–2015Patents assigned to DECKERT JUTTA (3)· patent assignee history
2013–2018Patents assigned to SANOFI SA (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMUNOGEN INC | 39 | 2008–2021 |
| TAVARES DANIELself | 7 | 2012–2014 |
| SANOFI SA | 6 | 2013–2018 |
| TAVARES DANIEL Jself | 4 | 2012–2016 |
| DECKERT JUTTA | 3 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Natick, Massachusetts, US | 47 | 2008–2021 |